1 / 4Nomura on Britannia Industries | Key risks include slower/faster volume growth in biscuits, said Nomura, maintaining its 'neutral' call on the company's stock. The brokerage said demand is holding up well but margin, not so much.
2 / 4Citi on Aurobindo Pharma | The brokerage that has maintained its 'buy' recommendation, would like to watch the company's guidance on margin outlook. Weakness in profitability is in-line with expectations, the brokerage added.
3 / 4JP Morgan on Britannia | The brokerage believes price hikes and cost measures are in place to support profitability going ahead. JP Morgan has an 'overweight' rating on shares of Britannia.
4 / 4Macquarie on Sun TV | Valuations are reasonable at current levels, said Macquarie that has retained its 'outperform' rating on shares of Sun TV. The brokerage pointed out that a key positive from Q2 results is a sharp recovery in advertising revenue.
